Merck (MRK) Current Assets (2009 - 2026)
Merck (MRK) reported Current Assets of $35.0 billion for Q1 2026, down 1.37% year-over-year from $35.5 billion in Q1 2025, and down 19.54% on a QoQ basis from $43.5 billion in Q4 2025.
Merck (MRK) has 18 years of Current Assets data on file, last reported at $35.0 billion in Q1 2026.
- Quarterly Current Assets fell 1.37% year-over-year to $35.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.0 billion (down 1.37% YoY) and the FY2025 annual result came in at $43.5 billion, up 12.21% from the prior year.
- Current Assets retreated to $35.0 billion in Q1 2026 per MRK's latest filing, from $43.5 billion in the prior quarter.
- Across five years, Current Assets topped out at $47.6 billion in Q3 2025 and bottomed at $30.0 billion in Q2 2023.
- The 5-year median for Current Assets is $35.0 billion (2026), against an average of $35.7 billion.
- The widest annual swing landed in 2023, when Current Assets retreated 9.95%; it then advanced 27.45% in 2024.
- Tracing MRK's Current Assets over 5 years: stood at $35.7 billion in 2022, then retreated by 9.95% to $32.2 billion in 2023, then climbed by 20.56% to $38.8 billion in 2024, then gained by 12.21% to $43.5 billion in 2025, then declined by 19.54% to $35.0 billion in 2026.
- Per Business Quant, the three latest MRK Current Assets figures stand at $35.0 billion (Q1 2026), $43.5 billion (Q4 2025), and $47.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 54.84 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 59.17 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 27.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 23.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.02 Bn |
| Dec 31, 2025 | 43.52 Bn |
| Sep 30, 2025 | 47.56 Bn |
| Jun 30, 2025 | 37.07 Bn |
| Mar 31, 2025 | 35.50 Bn |
| Dec 31, 2024 | 38.78 Bn |
| Sep 30, 2024 | 40.36 Bn |
| Jun 30, 2024 | 38.21 Bn |
| Mar 31, 2024 | 31.45 Bn |
| Dec 31, 2023 | 32.17 Bn |
| Sep 30, 2023 | 31.95 Bn |
| Jun 30, 2023 | 29.98 Bn |
| Mar 31, 2023 | 33.40 Bn |
| Dec 31, 2022 | 35.72 Bn |
| Sep 30, 2022 | 33.56 Bn |
| Jun 30, 2022 | 32.12 Bn |
| Mar 31, 2022 | 31.18 Bn |
| Dec 31, 2021 | 30.27 Bn |
| Sep 30, 2021 | 31.06 Bn |
| Jun 30, 2021 | 28.67 Bn |
| Mar 31, 2021 | 26.91 Bn |
| Dec 31, 2020 | 27.76 Bn |
| Sep 30, 2020 | 26.58 Bn |
| Jun 30, 2020 | 29.34 Bn |
| Mar 31, 2020 | 26.17 Bn |
| Dec 31, 2019 | 27.48 Bn |
| Sep 30, 2019 | 26.14 Bn |
| Jun 30, 2019 | 24.30 Bn |
| Mar 31, 2019 | 25.35 Bn |
| Dec 31, 2018 | 25.88 Bn |
| Sep 30, 2018 | 26.84 Bn |
| Jun 30, 2018 | 24.06 Bn |
| Mar 31, 2018 | 24.09 Bn |
| Dec 31, 2017 | 24.77 Bn |
| Sep 30, 2017 | 27.92 Bn |
| Jun 30, 2017 | 28.17 Bn |
| Mar 31, 2017 | 31.53 Bn |
| Dec 31, 2016 | 30.61 Bn |
| Sep 30, 2016 | 29.44 Bn |
| Jun 30, 2016 | 27.93 Bn |
| Mar 31, 2016 | 28.77 Bn |
| Dec 31, 2015 | 29.75 Bn |
| Sep 30, 2015 | 28.57 Bn |
| Jun 30, 2015 | 28.32 Bn |
| Mar 31, 2015 | 32.93 Bn |
| Dec 31, 2014 | 32.61 Bn |
| Sep 30, 2014 | 34.72 Bn |
| Jun 30, 2014 | 33.59 Bn |
| Mar 31, 2014 | 41.24 Bn |
| Dec 31, 2013 | 35.69 Bn |
| Sep 30, 2013 | 37.77 Bn |
| Jun 30, 2013 | 37.00 Bn |
| Dec 31, 2012 | 34.86 Bn |
| Jun 30, 2012 | 35.64 Bn |
| Mar 31, 2012 | 34.34 Bn |
| Dec 31, 2011 | 33.18 Bn |
| Sep 30, 2011 | 34.11 Bn |
| Jun 30, 2011 | 32.37 Bn |
| Mar 31, 2011 | 31.02 Bn |
| Dec 31, 2010 | 29.06 Bn |
| Sep 30, 2010 | 27.76 Bn |
| Jun 30, 2010 | 26.25 Bn |
| Mar 31, 2010 | 28.24 Bn |
| Dec 31, 2009 | 28.43 Bn |
| Sep 30, 2009 | 13.17 Bn |
| Jun 30, 2009 | 12.68 Bn |